CharlesSHemenwayMD
Pediatric Hematology & Oncology • Maywood, ILProfessor, Pediatrics, Loyola University Chicago Stritch School of Medicine
Dr. Hemenway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 South First Avenue
Maywood, IL 60153Phone+1 708-327-3130Fax+1 708-327-3342
Summary
- Dr. Charles Hemenway is a pediatric hematologist/oncologist in Maywood, IL. He received his medical degree from University of Massachusetts Medical School and has been in practice 30 years. He is experienced in general hematologic and oncologic diseases in children. His research focus is fusion oncogene proteins in childhood leukemia.
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1991 - 1995
University of Florida College of MedicineResidency, Internal Medicine/Pediatrics, 1987 - 1991
University of Massachusetts Medical SchoolClass of 1987
Certifications & Licensure
LA State Medical License 2022 - 2025
IL State Medical License 2007 - 2023
NC State Medical License 1995 - 1998
FL State Medical License 1989 - 1994- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 139 citationsImmunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.Maria E. Cardenas, Charles Hemenway, R. S. Muir, R Ye, David Fiorentino
The EMBO Journal. 1994-12-15 - 80 citationsDegree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation PotentialAravinda Kuntimaddi, Nicholas J. Achille, Jeremy Thorpe, Alyson A. Lokken, Ritambhara Singh
Cell Reports. 2015-05-05 - 194 citationsCalcineurin. Structure, function, and inhibition.Charles S. Hemenway, Joseph Heitman
Cell Biochemistry and Biophysics. 1999-01-01
Press Mentions
Children’s Hospital New Orleans Designated for New Sickle Cell Gene TherapyMarch 11th, 2024
Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
Grant Support
- Structure/Function Of AF9 And MLL-AF9National Cancer Institute2011
- Targeted Therapy For 11Q23 Acute LeukemiasNational Cancer Institute2009–2011
- Disrupting The AF4-AF9 Protein Complex In MLL Leukemias.National Cancer Institute2008–2009
- Tulane Cancer Genetics Cobre: Inovative Therapies For T(4;11) LeukemiaNational Center For Research Resources2004–2008
- Targeted Therapy For 11Q23 Acute Leukemias.National Cancer Institute2004–2007
- BMI1 Interacting Proteins In Neoplastic TransformationNational Cancer Institute1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
